Αναζήτηση Δραστικών

MITOTANE

Εμπορικές Ονομασίες

  • DRUGBANK - Mitotane
  • indication:

    For treatment of inoperable adrenocortical tumours; Cushing's syndrome

  • pharmacology:

  • mechanism:

    Its biochemical mechanism of action is unknown, although data are available to suggest that the drug modifies the peripheral metabolism of steroids as well as directly suppressing the adrenal cortex.

  • toxicity:

  • absorprion:

    About 40% oral Lysodren is absorbed

  • halflife:

    18-159 days

  • roouteelimination:

    A variable amount of metabolite (1%-17%) is excreted in the bile and the balance is apparently stored in the tissues.

  • volumedistribution:

  • clearance: